Feb 06

Beech Tree Labs, Inc., has announced that the FDA has approved its IND for a 180 patient Phase 1/2a clinical evaluation of BTL-TML001, a novel therapeutic agent for treating acute influenza virus infections.

In the US outbreaks of seasonal flu are estimated to incur annual costs of more than $12bn, with a mortality rate of over 36,000 people. In the case of a pandemic, estimated annual costs would range from $71bn to $167bn for attack rates of 15%-35% of the population.

Beech Tree Labs is a privately held biopharmaceutical company specialising in discovery and early-s…

written by The Scientist


5 Responses to “FDA Approves Beech Tree Labs’ Influenza IND Application”

  1. 1. discount ghd Says:

    Discount ghd straighteners and CHI Flat irons here,try to place an order of ghd hair straighteners.

  2. 2. coach Says:

    Welcome to coach outlet to buy coach bags,coach purses and coach handbagsare enjoy top quality and free shipping.

  3. 3. christian louboutin Says:

    which deals with applying the available regulatory guidelines on method validation, such as ICH and FDA, to methods used for the chemical analysis of pharmaceuticals.

  4. 4. coach bags Says:

    coach outlet include coach pursesandcoach handbags,all of them are your best choice.

  5. 5. Wholesale Says:

    Wholesale NFL JerseysWholesale NFL Jerseys
    NFL JerseysNFL Jerseys

Leave a Reply